• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Expression of c-erbB-2 protein product in bladder cancer.

作者信息

Wright C, Mellon K, Neal D E, Johnston P, Corbett I P, Horne C H

机构信息

Department of Pathology, University of Newcastle upon Tyne, Royal Victoria Infirmary, UK.

出版信息

Br J Cancer. 1990 Nov;62(5):764-5. doi: 10.1038/bjc.1990.375.

DOI:10.1038/bjc.1990.375
PMID:1978784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1971522/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c86/1971522/bb22af67729a/brjcancer00219-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c86/1971522/bb22af67729a/brjcancer00219-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c86/1971522/bb22af67729a/brjcancer00219-0067-a.jpg

相似文献

1
Expression of c-erbB-2 protein product in bladder cancer.c-erbB-2蛋白产物在膀胱癌中的表达。
Br J Cancer. 1990 Nov;62(5):764-5. doi: 10.1038/bjc.1990.375.
2
c-erbB-2 gene product-like expression in urothelial carcinomas of the human bladder. Its value as a prognostic indicator in superficial tumors.人膀胱尿路上皮癌中c-erbB-2基因产物样表达。其作为浅表性肿瘤预后指标的价值。
Pathologica. 1991 Jul-Aug;83(1086):413-20.
3
Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.
J Pathol. 1991 Aug;164(4):285-9. doi: 10.1002/path.1711640403.
4
Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer.c-erbB-2蛋白在正常和肿瘤性尿路上皮中的表达：对人类膀胱癌无不良预后影响
Anticancer Res. 1994 May-Jun;14(3B):1317-24.
5
The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.p53、MDM2和c-erb B-2癌蛋白、表皮生长因子受体及增殖标志物在膀胱癌预后中的作用
Pathol Res Pract. 1997;193(11-12):767-75. doi: 10.1016/S0344-0338(97)80055-6.
6
Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.乳腺癌中c-erbB-2癌蛋白表达的免疫组织化学研究。
Oncology. 1994 Jan-Feb;51(1):47-51. doi: 10.1159/000227309.
7
[Overexpression of c-erbB-2 proto-oncogene product in chondrosarcomas].[软骨肉瘤中c-erbB-2原癌基因产物的过表达]
Zhonghua Bing Li Xue Za Zhi. 1994 Feb;23(1):37-9.
8
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.晚期乳腺癌中c-erbB-2蛋白产物表达与内分泌治疗反应的关系。
Br J Cancer. 1992 Jan;65(1):118-21. doi: 10.1038/bjc.1992.22.
9
Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.人胃癌中表皮生长因子受体和c-erbB-2原癌基因的扩增与过表达。
Br J Cancer. 1991 Jul;64(1):79-83. doi: 10.1038/bjc.1991.243.
10
Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.非艾滋病相关地中海型卡波西肉瘤中Ras、C-myc和C-erbB-2癌蛋白的表达
Anticancer Res. 1990 Nov-Dec;10(6):1619-25.

引用本文的文献

1
Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder.HER2、吲哚胺2,3-双加氧酶和PD-L1在膀胱尿路上皮癌中的差异表达及临床病理意义
J Clin Med. 2020 Apr 27;9(5):1265. doi: 10.3390/jcm9051265.
2
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).一项针对非膀胱切除术候选的肌层浸润性膀胱癌患者经尿道手术后，使用紫杉醇和曲妥珠单抗联合每日放疗或单独使用紫杉醇联合每日放疗的1/2期试验（试验编号：NRG肿瘤学RTOG 0524）。
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):995-1001. doi: 10.1016/j.ijrobp.2016.12.018. Epub 2016 Dec 19.
3

本文引用的文献

1
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.Ha-ras癌基因在人类泌尿系统肿瘤中因体细胞改变而被激活。
Nature. 1984;309(5967):464-6. doi: 10.1038/309464a0.
2
Oncogenes and bladder cancer.
Br J Urol. 1985 Dec;57(6):664-7. doi: 10.1111/j.1464-410x.1985.tb07028.x.
3
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.一种与癌基因编码的肿瘤抗原反应的单克隆抗体对肿瘤生长的抑制作用。
Proc Natl Acad Sci U S A. 1986 Dec;83(23):9129-33. doi: 10.1073/pnas.83.23.9129.
Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles.凋亡素通过改变多种膀胱肿瘤相关基因表达谱，在人膀胱癌裸鼠异种移植模型中诱导细胞凋亡。
Tumour Biol. 2013 Jun;34(3):1667-78. doi: 10.1007/s13277-013-0700-8. Epub 2013 Feb 22.
4
Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma.
Virchows Arch. 2004 May;444(5):415-9. doi: 10.1007/s00428-004-0986-4. Epub 2004 Mar 17.
5
HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder.HER2/neu过表达在膀胱肌层浸润性移行细胞癌发生发展中的作用
Br J Cancer. 2003 Oct 6;89(7):1305-9. doi: 10.1038/sj.bjc.6601245.
6
Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.评估表皮生长因子受体、转化生长因子α、表皮生长因子和c-erbB2在浸润性膀胱癌进展中的作用。
Urol Res. 1997;25(1):9-17. doi: 10.1007/BF00941900.
7
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.可手术切除的肌层浸润性膀胱癌中DNA倍体和S期细胞分数的临床意义及其与p53蛋白、c-erbB-2蛋白和人绒毛膜促性腺激素的关系
Br J Cancer. 1993 Sep;68(3):572-8. doi: 10.1038/bjc.1993.388.
8
Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.癌基因ras和c-erbB-2的表达与膀胱肿瘤生物学行为之间的相关性。
Urol Res. 1993 Jan;21(1):39-43. doi: 10.1007/BF00295190.
9
C-erbB-2 immunostaining: problems with interpretation.C-erbB-2免疫染色：解读问题
J Clin Pathol. 1994 Sep;47(9):816-22. doi: 10.1136/jcp.47.9.816.
10
The neu-protein and breast cancer.神经蛋白与乳腺癌
Virchows Arch. 1995;426(2):107-15. doi: 10.1007/BF00192631.
4
Evaluation of epidermal growth factor receptors in bladder tumours.膀胱肿瘤中表皮生长因子受体的评估
Br J Cancer. 1987 Nov;56(5):533-7. doi: 10.1038/bjc.1987.238.
5
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.HER2/neu原癌基因在各种组织腺癌中的散发性扩增。
Cancer Res. 1988 Mar 15;48(6):1517-20.
6
Expression of the c-erbB-2 protein in normal and transformed cells.c-erbB-2蛋白在正常细胞和转化细胞中的表达。
Int J Cancer. 1987 Aug 15;40(2):246-54. doi: 10.1002/ijc.2910400221.
7
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.在携带激活型c-neu癌基因的转基因小鼠中一步诱导乳腺腺癌
Cell. 1988 Jul 1;54(1):105-15. doi: 10.1016/0092-8674(88)90184-5.
8
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.假定的生长因子受体p185HER2的表达增加会导致NIH 3T3细胞发生转化和肿瘤形成。
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7159-63. doi: 10.1073/pnas.84.20.7159.
9
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.人膀胱癌中的表皮生长因子受体：浸润性肿瘤与浅表性肿瘤的比较
Lancet. 1985 Feb 16;1(8425):366-8. doi: 10.1016/s0140-6736(85)91386-8.
10
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.c-erbB-2基因在人小细胞肺癌和非小细胞肺癌中的差异表达
Cancer Res. 1989 Sep 15;49(18):4968-71.